Psychedelic Institute ProjectMay 2, 2025
https://pubmed.ncbi.nlm.nih.gov/40313650/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Jks6COFDAP2wn10NWIf-H0HaQXEJkWUqtjQ12xwhgtqZed1QU&fc=20250204204106&ff=20250502062629&v=2.18.0.post9+e462414 Intravenous Ketamine Treatment for Depression: One-year Retrospective Study from a Tertiary Care Psychiatry Center from India (Yadev, et al, 2025) #ketamine #psychedelic #ketaminetherapy #psychedelics #psychedelicresesrch #mentalhealth #ketaminesafety #depression #neuroscience
Intravenous Ketamine Treatment for Depression: One-year Retrospective Study from a Tertiary Care Psychiatry Center from India - PubMed

The finding of this study indicates that ketamine infusion therapy is safe and effective as a rapidly acting adjunct treatment for depression.

PubMed